Bayer's Pharma Division Navigates Patent Expirations with Strong Portfolio

Bayer's pharmaceutical division is reportedly managing the expiration of its blockbuster drug patents better than anticipated, with the board highlighting its strongest portfolio in history. This growth, however, brings high expectations and significant risks.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

fazGerman8h ago

Starke Pharmasparte: Wie Bayer die nächste Patentklippe umschiffen will

Besser als erwartet verdaut die Pharmasparte des Dax-Konzerns die auslaufenden Patente seiner Blockbuster. Vom gar leistungsstärksten Portfolio in der Geschichte spricht der Vorstand. Das Wachstum bringt hohe Erwartungen – und großes Risiko.

Read full article →

PERSPECTA

PERSPECTA

Bayer's Pharma Division Navigates Patent Expirations with Strong Portfolio

Sources

Starke Pharmasparte: Wie Bayer die nächste Patentklippe umschiffen will

Related Stories

Oil Prices Rise After Previous Day's Sharp Drop

Sandro Marcos seeks bank fee waivers amid Middle East crisis

Philippine Lottery Draws on April 10 Yield No Jackpot Winners

Philippines Seeks P8 Billion Budget for Fuel Stockpiling

PERSPECTA